Procter & Gamble (PG) Shareholder Daniel Devine & Company Has Lowered Its Position as Valuation Declined; Paratek Pharmaceuticals (PRTK) Holder Roumell Asset Management Cut Its Position as Market Valuation Rose

February 17, 2018 - By Linda Rogers

Daniel Devine & Company decreased its stake in Procter & Gamble (PG) by 54.69% based on its latest 2017Q3 regulatory filing with the SEC. Daniel Devine & Company sold 4,387 shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 3,635 shares of the package goods and cosmetics company at the end of 2017Q3, valued at $331,000, down from 8,022 at the end of the previous reported quarter. Daniel Devine & Company who had been investing in Procter & Gamble for a number of months, seems to be less bullish one the $208.24B market cap company. The stock increased 0.23% or $0.19 during the last trading session, reaching $82.6. About 10.37 million shares traded or 22.36% up from the average. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since February 17, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Jim Roumell decreased its stake in Paratek Pharmaceuticals Inc (PRTK) by 60.66% based on its latest 2017Q3 regulatory filing with the SEC. Roumell Asset Management Llc sold 156,349 shares as the company’s stock rose 33.85% with the market. The hedge fund run by Jim Roumell held 101,399 shares of the health care company at the end of 2017Q3, valued at $2.55 million, down from 257,748 at the end of the previous reported quarter. Roumell Asset Management Llc who had been investing in Paratek Pharmaceuticals Inc for a number of months, seems to be less bullish one the $434.58M market cap company. The stock increased 0.18% or $0.025 during the last trading session, reaching $13.975. About 424,128 shares traded. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has risen 62.03% since February 17, 2017 and is uptrending. It has outperformed by 45.33% the S&P500.

Among 10 analysts covering Paratek Pharmaceuticals (NASDAQ:PRTK), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Paratek Pharmaceuticals had 24 analyst reports since July 23, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, November 8 report. Robert W. Baird maintained Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) on Tuesday, October 24 with “Buy” rating. Ladenburg Thalmann maintained it with “Buy” rating and $52 target in Friday, June 17 report. The stock of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) earned “Hold” rating by Zacks on Saturday, August 8. The firm earned “Hold” rating on Tuesday, September 22 by Zacks. Leerink Swann maintained Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) on Thursday, June 15 with “Buy” rating. On Wednesday, June 21 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Zacks upgraded the shares of PRTK in report on Friday, August 14 to “Sell” rating. Robert W. Baird initiated the stock with “Outperform” rating in Friday, May 13 report. The stock of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has “Buy” rating given on Thursday, June 29 by Cantor Fitzgerald.

Analysts await Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) to report earnings on March, 1. They expect $-0.72 EPS, up 37.93% or $0.44 from last year’s $-1.16 per share. After $-0.77 actual EPS reported by Paratek Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -6.49% EPS growth.

Investors sentiment decreased to 1.54 in Q3 2017. Its down 0.35, from 1.89 in 2017Q2. It dived, as 17 investors sold PRTK shares while 29 reduced holdings. 33 funds opened positions while 38 raised stakes. 20.11 million shares or 4.43% more from 19.26 million shares in 2017Q2 were reported. Millennium Llc reported 334,353 shares. Trellus Mngmt Comm Ltd Liability Company reported 20,000 shares. Quantbot Tech Ltd Partnership reported 7,649 shares or 0.02% of all its holdings. Bnp Paribas Arbitrage Sa has 2,386 shares. 1.93 million are held by Blackrock. Marshall Wace Llp stated it has 0.05% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Deutsche Retail Bank Ag has invested 0.01% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Zurcher Kantonalbank (Zurich Cantonalbank) holds 677 shares. Great West Life Assurance Can reported 0% of its portfolio in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). New York-based Laurion Management Lp has invested 0% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). State Of Wisconsin Investment Board invested in 16,000 shares. Numeric Investors Ltd Company holds 0.04% or 233,120 shares in its portfolio. Raymond James Advsr reported 0% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Renaissance Tech Ltd Liability Com invested 0.01% of its portfolio in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Next Fincl Grp has invested 0% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK).

Roumell Asset Management Llc, which manages about $293.14M and $42.50M US Long portfolio, upped its stake in Five Point Holdings Llc by 47,291 shares to 152,620 shares, valued at $2.08M in 2017Q3, according to the filing. It also increased its holding in Rubicon Proj Inc (NYSE:RUBI) by 153,305 shares in the quarter, for a total of 670,565 shares, and has risen its stake in Great Elm Cap Group Inc.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.12, from 0.94 in 2017Q2. It is negative, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Stonebridge Cap Mngmt Inc has 1.13% invested in The Procter & Gamble Company (NYSE:PG) for 32,949 shares. Jensen Invest Mgmt has 3.65% invested in The Procter & Gamble Company (NYSE:PG). Alexandria Capital Ltd Limited Liability Company has invested 0.17% in The Procter & Gamble Company (NYSE:PG). Guinness Atkinson Asset Mngmt accumulated 2,590 shares. Investors stated it has 0.67% of its portfolio in The Procter & Gamble Company (NYSE:PG). S R Schill Assocs holds 0.54% or 9,832 shares in its portfolio. South State owns 144,095 shares. 2.13 million are held by Robeco Institutional Asset Management Bv. Regal Investment Advsr Ltd Llc owns 52,654 shares for 1.12% of their portfolio. 300 were accumulated by James Invest Rech. Columbia Prtnrs L L C Inv Management accumulated 2,456 shares. Magnetar Limited Liability Co invested in 9,400 shares. New Jersey-based Quantum Mngmt Nj has invested 0% in The Procter & Gamble Company (NYSE:PG). National Co Tx holds 275,100 shares or 1.32% of its portfolio. First Trust Lp reported 0.35% stake.

Since August 15, 2017, it had 0 insider purchases, and 3 insider sales for $3.16 million activity. On Tuesday, August 15 Pritchard Marc S. sold $339,077 worth of The Procter & Gamble Company (NYSE:PG) or 3,684 shares. $321,221 worth of The Procter & Gamble Company (NYSE:PG) shares were sold by FergusonMchugh MaryLynn. Another trade for 1,257 shares valued at $115,695 was made by Matthew Price on Tuesday, August 15. Skoufalos Ioannis sold $266,273 worth of stock or 2,893 shares. 4,591 shares valued at $401,642 were sold by Majoras Deborah P on Saturday, September 30. Pierce Charles E sold $323,891 worth of stock or 3,519 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>